Xiaomin Niu

机构：Zhongshan People's Hospital · ORCID：0000-0003-1079-1785

发表论文 154 篇 · 总被引 2420 次 · h-index 29

代表论文

• Immunotherapy resistance in non-small cell lung cancer: from mechanisms to therapeutic opportunities (2025 · Journal of Experimental & Clinical Cancer Research · 被引 38)
• FBLN2 is associated with Goldenhar syndrome and is essential for cranial neural crest cell development (2024 · Annals of the New York Academy of Sciences · 被引 11)
• Immunotherapy for small cell lung cancer: current challenges and prospects (2025 · Experimental Hematology and Oncology · 被引 10)
• Myricetin inhibits 4 T1 breast tumor growth in mice via induction of Nrf-2/GPX4 pathway-mediated Ferroptosis (2024 · Toxicology and Applied Pharmacology · 被引 10)
• Expert consensus on the diagnosis and treatment of non-small cell lung cancer with MET alteration (2025 · Cancer Biology and Medicine · 被引 7)
• Co-delivery of doxorubicin-dihydroartemisinin prodrug/TEPP-46 nano-liposomes for improving antitumor and decreasing cardiotoxicity in B16-F10 tumor-bearing mice (2024 · Colloids and Surfaces B Biointerfaces · 被引 7)